New pill could ease Diabetes-Related vision loss
NCT ID NCT04187443
First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 32 times
Summary
This early-stage trial tests an oral drug called MS-553 in 45 people with diabetic macular edema, a condition where diabetes causes fluid buildup in the eye's center, blurring vision. Participants take the drug daily for 8 weeks to check its safety and whether it reduces swelling or improves eyesight. The goal is to find a convenient pill-based treatment for this common diabetes complication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai General Hospital
RECRUITINGShanghai, 200080, China
Contact
Contact
-
The Second Xiangya Hospital of Central South University
RECRUITINGChangsha, Hunan, China
-
West China Hospital of Sichuan University
RECRUITINGChengdu, Sichuan, China
Conditions
Explore the condition pages connected to this study.